Ins ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has received IND clearance from FDA for ISM5939, a potential best-in-class ...

Medically reviewed by Mary Choy, PharmD Hydroxyzine is a commonly prescribed antihistamine medication for anxiety and ...

A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...

On September 12 th, Bright Minds Biosciences announced the initiation of the BREAKTHROUGH Study, an open-label Phase 2 ...

Healthcare looks to be entering a golden age, driven by demographic shifts that look capable of driving growth for years, if ...

Researchers have led a clinical trial of a drug that mimics the effects of alcohol in more than 100 patients with laryngeal dystonia, a neurological condition that causes involuntary muscle spasms in ...

A new study out of Boston shows the promise of an alcohol-mimicking drug for patients with a debilitating neurological voice ...

CLEVELAND (WJW) – There are more emergency department visits for alcohol than any other drug. That’s according to new data ...

Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.

Nrx Pharmaceuticals, Inc. ( (NRXP) ) has released its Q3 earnings. Here is a breakdown of the information Nrx Pharmaceuticals, Inc. presented ...